Dr. Albert J (Arjan) Bredenoord studied Medicine in Antwerp, Belgium. He subsequently worked on several clinical research projects on gastrointestinal motility at the University of Utrecht, the Netherlands which resulted in the completion of his Ph.D. thesis on gastroesophageal reflux disease in 2006. His clinical training was performed in Nieuwegein, the Netherlands, and at the Royal London Hospital in London, UK. He currently works as a consultant Gastroenterologist at the Amsterdam University Medical Center where he is dedicated to patient care, scientific research, and education in the field of benign esophageal diseases. He was appointed professor of Neurogastroenterology & Motility at the University of Amsterdam in 2019.
Dr. Bredenoord’s main focus is on achalasia, reflux disease, and eosinophilic esophagitis. The esophageal clinic in AMC Amsterdam hosts the largest population of benign esophageal diseases in the Netherlands. Dr. Bredenoord is an author of over 250 papers, books, and book chapters on esophageal diseases and organizes regular courses in Europe, North America, and Asia. Dr. Bredenoord is President of the European Society of Eosinophilic Esophagitis EUREOS, a member of the UEG Scientific Committee, and co-founder of the International HRM working group. He collaborates with Alimentiv on studies on endpoint development for clinical trials in eosinophilic esophagitis and advises on all stages of trial design in drug development for eosinophilic esophagitis.
